Cargando…

Ultrasonography and clinicopathological features of breast cancer in predicting axillary lymph node metastases

BACKGROUND: Early identification of axillary lymph node metastasis (ALNM) in breast cancer (BC) is still a clinical difficulty. There is still no good method to replace sentinel lymph node biopsy (SLNB). The purpose of our study was to develop and validate a nomogram to predict the probability of AL...

Descripción completa

Detalles Bibliográficos
Autores principales: Xiong, Jiajia, Zuo, Wei, Wu, Yu, Wang, Xiuhua, Li, Wenqu, Wang, Qiaodan, Zhou, Hui, Xie, Mingxing, Qin, Xiaojuan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9647900/
https://www.ncbi.nlm.nih.gov/pubmed/36352378
http://dx.doi.org/10.1186/s12885-022-10240-z
_version_ 1784827468565184512
author Xiong, Jiajia
Zuo, Wei
Wu, Yu
Wang, Xiuhua
Li, Wenqu
Wang, Qiaodan
Zhou, Hui
Xie, Mingxing
Qin, Xiaojuan
author_facet Xiong, Jiajia
Zuo, Wei
Wu, Yu
Wang, Xiuhua
Li, Wenqu
Wang, Qiaodan
Zhou, Hui
Xie, Mingxing
Qin, Xiaojuan
author_sort Xiong, Jiajia
collection PubMed
description BACKGROUND: Early identification of axillary lymph node metastasis (ALNM) in breast cancer (BC) is still a clinical difficulty. There is still no good method to replace sentinel lymph node biopsy (SLNB). The purpose of our study was to develop and validate a nomogram to predict the probability of ALNM preoperatively based on ultrasonography (US) and clinicopathological features of primary tumors. METHODS: From September 2019 to April 2022, the preoperative US) and clinicopathological data of 1076 T1-T2 BC patients underwent surgical treatment were collected. Patients were divided into a training set (875 patients from September 2019 to October 2021) and a validation set (201 patients from November 2021 to April 2022). Patients were divided into positive and negative axillary lymph node (ALN) group according pathology of axillary surgery. Compared the US and clinicopathological features between the two groups. The risk factors for ALNM were determined using multivariate logistic regression analysis, and a nomogram was constructed. AUC and calibration were used to assess its performance. RESULTS: By univariate and multivariate logistic regression analysis, age (p = 0.009), histologic grades (p = 0.000), molecular subtypes (p = 0.000), tumor location (p = 0.000), maximum diameter (p = 0.000), spiculated margin (p = 0.000) and distance from the skin (p = 0.000) were independent risk factors of ALNM. Then a nomogram was developed. The model was good discriminating with an AUC of 0.705 and 0.745 for the training and validation set, respectively. And the calibration curves demonstrated high agreement. However, in further predicting a heavy nodal disease burden (> 2 nodes), none of the variables were significant. CONCLUSION: This nomogram based on the US and clinicopathological data can predict the presence of ALNM good in T1-T2 BC patients. But it cannot effectively predict a heavy nodal disease burden (> 2 nodes).
format Online
Article
Text
id pubmed-9647900
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-96479002022-11-15 Ultrasonography and clinicopathological features of breast cancer in predicting axillary lymph node metastases Xiong, Jiajia Zuo, Wei Wu, Yu Wang, Xiuhua Li, Wenqu Wang, Qiaodan Zhou, Hui Xie, Mingxing Qin, Xiaojuan BMC Cancer Research BACKGROUND: Early identification of axillary lymph node metastasis (ALNM) in breast cancer (BC) is still a clinical difficulty. There is still no good method to replace sentinel lymph node biopsy (SLNB). The purpose of our study was to develop and validate a nomogram to predict the probability of ALNM preoperatively based on ultrasonography (US) and clinicopathological features of primary tumors. METHODS: From September 2019 to April 2022, the preoperative US) and clinicopathological data of 1076 T1-T2 BC patients underwent surgical treatment were collected. Patients were divided into a training set (875 patients from September 2019 to October 2021) and a validation set (201 patients from November 2021 to April 2022). Patients were divided into positive and negative axillary lymph node (ALN) group according pathology of axillary surgery. Compared the US and clinicopathological features between the two groups. The risk factors for ALNM were determined using multivariate logistic regression analysis, and a nomogram was constructed. AUC and calibration were used to assess its performance. RESULTS: By univariate and multivariate logistic regression analysis, age (p = 0.009), histologic grades (p = 0.000), molecular subtypes (p = 0.000), tumor location (p = 0.000), maximum diameter (p = 0.000), spiculated margin (p = 0.000) and distance from the skin (p = 0.000) were independent risk factors of ALNM. Then a nomogram was developed. The model was good discriminating with an AUC of 0.705 and 0.745 for the training and validation set, respectively. And the calibration curves demonstrated high agreement. However, in further predicting a heavy nodal disease burden (> 2 nodes), none of the variables were significant. CONCLUSION: This nomogram based on the US and clinicopathological data can predict the presence of ALNM good in T1-T2 BC patients. But it cannot effectively predict a heavy nodal disease burden (> 2 nodes). BioMed Central 2022-11-09 /pmc/articles/PMC9647900/ /pubmed/36352378 http://dx.doi.org/10.1186/s12885-022-10240-z Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Xiong, Jiajia
Zuo, Wei
Wu, Yu
Wang, Xiuhua
Li, Wenqu
Wang, Qiaodan
Zhou, Hui
Xie, Mingxing
Qin, Xiaojuan
Ultrasonography and clinicopathological features of breast cancer in predicting axillary lymph node metastases
title Ultrasonography and clinicopathological features of breast cancer in predicting axillary lymph node metastases
title_full Ultrasonography and clinicopathological features of breast cancer in predicting axillary lymph node metastases
title_fullStr Ultrasonography and clinicopathological features of breast cancer in predicting axillary lymph node metastases
title_full_unstemmed Ultrasonography and clinicopathological features of breast cancer in predicting axillary lymph node metastases
title_short Ultrasonography and clinicopathological features of breast cancer in predicting axillary lymph node metastases
title_sort ultrasonography and clinicopathological features of breast cancer in predicting axillary lymph node metastases
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9647900/
https://www.ncbi.nlm.nih.gov/pubmed/36352378
http://dx.doi.org/10.1186/s12885-022-10240-z
work_keys_str_mv AT xiongjiajia ultrasonographyandclinicopathologicalfeaturesofbreastcancerinpredictingaxillarylymphnodemetastases
AT zuowei ultrasonographyandclinicopathologicalfeaturesofbreastcancerinpredictingaxillarylymphnodemetastases
AT wuyu ultrasonographyandclinicopathologicalfeaturesofbreastcancerinpredictingaxillarylymphnodemetastases
AT wangxiuhua ultrasonographyandclinicopathologicalfeaturesofbreastcancerinpredictingaxillarylymphnodemetastases
AT liwenqu ultrasonographyandclinicopathologicalfeaturesofbreastcancerinpredictingaxillarylymphnodemetastases
AT wangqiaodan ultrasonographyandclinicopathologicalfeaturesofbreastcancerinpredictingaxillarylymphnodemetastases
AT zhouhui ultrasonographyandclinicopathologicalfeaturesofbreastcancerinpredictingaxillarylymphnodemetastases
AT xiemingxing ultrasonographyandclinicopathologicalfeaturesofbreastcancerinpredictingaxillarylymphnodemetastases
AT qinxiaojuan ultrasonographyandclinicopathologicalfeaturesofbreastcancerinpredictingaxillarylymphnodemetastases